Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Caffeine Withdrawal clinical trials
A small indexed set (2 trials) with no open enrollment listed right now.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · none currently recruiting · #7,188 of 28,707 conditions by registered trial count
Caffeine Withdrawal: 2 US clinical trials tracked, none currently recruiting.
Caffeine Withdrawal is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is Iovate Health Sciences International, running 1 of these trials.
Enrollment posture brief
Registry condition caffeine-withdrawal
OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Caffeine Withdrawal has no open enrollment in this registry pull (2 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Caffeine Withdrawal on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Caffeine Withdrawal is recruiting below its size-band peers.
0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
2 total, page 1 of 1
Effect of Different Dosages of Paraxanthine, the Major Caffeine Metabolite, on Energy and Focus
Iovate Health Sciences International
NCT06117280
A Single-Arm, Virtual Clinical Trial to Evaluate the Effects of a Sleep Supporting Beverage and Two Coffee Substitute Products
Clevr Blends
NCT06146517
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Caffeine Withdrawal records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Caffeine Withdrawal trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Caffeine Withdrawal page
2 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Caffeine Withdrawal trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Iovate Health Sciences International sponsors the most Caffeine Withdrawal trials on record, review their full trial history before evaluating a specific study. See Iovate Health Sciences International's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Caffeine Withdrawal condition card totals 2 registered trials; most-linked intervention Paraxanthine 300 mg; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.